Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TRVI compared with SVRA: revenue, margins and what each company keeps, and the suppliers and customers both name
TRVI
Trevi Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
SVRA
Savara Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
TRVI
Trevi Therapeutics, Inc.
vs
SVRA
Savara Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
TRVI
0 of 4
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±14.8%
▲
+0.05%
×0.01
May 6 '26
±8.2%
▼
−2.73%
×0.33
Apr 17 '26
±17.5%
▲
+4.75%
×0.27
Q1 FY26
±11.9%
▼
−4.47%
×0.38
SVRA
No earnings history for SVRA.
= implied
TRVI realized, solid
SVRA realized, hatched
One scale, both sides: full bar = 18%
× = |realized| ÷ implied
Source: market data
TRVI
Trevi Therapeutics, Inc.
Change
14.33
▲
+11.87%
· post 15.14
Mkt cap
$2.0B
SVRA
Savara Inc
Change
4.83
▲
+10.27%
· post 4.84
Closed
Nov 6 '26
Mkt cap
$992.4M
vs
Compare
Closed
Nov 6 '26
TRVI
Trevi Therapeutics, Inc.
vs
SVRA
Savara Inc
14.33
▲
+11.87%
post 15.14
Price
4.83
▲
+10.27%
post 4.84
$2.0B
Mkt cap
$992.4M
Change
Change
TRVI
14.33
▲
+11.87%
vs
SVRA
4.83
▲
+10.27%
Closed
Nov 6 '26